SGLT2 inhibitors: Do they have antiarrhythmic properties?

Pharmacology & Therapeutics 2026

View at publisher
Authors: Ricardo Caballero, Juan Tamargo, Eva Delpón
DOI: 10.1016/j.pharmthera.2025.108973
Cited by: 4
References: 245

Fields of Study & Subjects

Diabetes Treatment and Management Cardiovascular Function and Risk Factors Heart Failure Treatment and Management

Publication details

Journal / source
Pharmacology & Therapeutics
Publisher
Elsevier BV
Volume
279
Pages
108973–108973
Publication date
5 January 2026
Language
EN